FEEDBACK on PHARMAC’s
consultation regarding a draft
RFP for the supply of medicines
for rare disorders has supported
trialling the proposed approach of
a commercial process to fund these
medicines (PD 09 May).
The organisation said most
submissions felt NZ$5m per year of
contestable funding over five years
was not enough, and that some
submissions highlighted a lack of
clarity as to whether funding was
ongoing after the five years.
PHARMAC said medicines listed
would continue to be available as
long as people continued to benefit
from them.
A number of prerequisites have
been updated, which can be
accessed by CLICKING HERE.The above article was sent to subscribers in Pharmacy Daily's issue from 18 Aug 14 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 18 Aug 14
THE vaping reforms bill passed in the Senate this week has raised significant questions around pharmacy insurance premiums, business risks and regulatory compliance for community pharmacists, according to the profession’s peak body.
A COMBINATION of varenicline and nicotine lozenges may be a more effective treatment option for people looking to quit smoking compared to varenicline alone, according to results from a new clinical trial at Monash University.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.